HHC ACO Inc., an Accountable Care Organization
Medicare Shared Savings Program
The HHC ACO is participating in the Medicare Shared Savings Program (MSSP). The HHC ACO encourages investment in infrastructure and redesigned care processes for high quality and efficient service delivery and works to meet and exceed the quality of care performance standard defined by CMS and determined using nationally recognized measures in four key areas:
- Patient/caregiver experience
- Care coordination/patient safety
- Preventive health
- At-risk population (diabetes, hypertension, ischemic vascular disease, heart failure and coronary artery disease)
Amount of Shared Savings / Losses
- Performance Year 1: $3,639,766
- Performance Year 2: $2,644,605
- Performance Year 3: TBD
How Shared Savings Are Distributed
i. Up to 100% retained by HHC ACO as an offset to costs incurred in developing and maintaining the ACO’s infrastructure and operations.
ii. If MSSP shared savings payments exceed the amounts described in (i):
- 50% to HHC for reinvestment in meeting the goals of HHC ACO; and
- 50% to ACO participants, proportional to the number of full-time equivalent primary care providers employed by the participant
Quality Performance Results
2013 Performance Summary Statistics |
||
Performance Measure |
ACO Performance Rate |
Mean Performance Rate for All ACOs |
Getting Timely Care, Appointments, and Information (ACO-1) |
70.19 |
81.48 |
How Well Your Doctors Communicate (ACO-2) |
89.16 |
92.96 |
Patients’ Rating of Doctor (ACO-3) |
89.18 |
92.06 |
Access to Specialists (ACO-4) |
75.92 |
85.12 |
Health Promotion and Education (ACO-5) |
63.24 |
58.38 |
Shared Decision Making (ACO-6) |
70.62 |
74.53 |
Health Status/Functional Status (ACO-7) |
70.35 |
71.12 |
Risk Standardized, All Condition Readmissions (ACO-8) |
16.32 |
14.9 |
ASC Admissions: COPD or Asthma in Older Adults (ACO-9) |
3.1 |
1.17 |
ASC Admission: Heart Failure (ACO-10) |
2.06 |
1.2 |
Percent of Primary Care Providers who Qualified for EHR Incentive Payment (ACO-11) |
2.86% |
66.21% |
Medication Reconciliation (ACO-12) |
93.07% |
73.56% |
Falls: Screening for Fall Risk (ACO-13) |
49.56% |
39.57% |
Influenza Immunization (ACO-14) |
75.29% |
56.93% |
Pneumococcal Vaccination (ACO-15) |
79.52% |
54.76% |
Adult Weight Screening and Follow-up (ACO-16) |
59.34% |
61.61% |
Tobacco Use Assessment and Cessation Intervention (ACO-17) |
88.40% |
84.01% |
Depression Screening (ACO-18) |
86.57% |
31.19% |
Colorectal Cancer Screening (ACO-19) |
75.57% |
59.30% |
Mammography Screening (ACO-20) |
76.41% |
62.05% |
Proportion of Adults who had blood pressure screened in past 2 years (ACO-21) |
67.04% |
74.25% |
Beneficiaries with diabetes who met of all the following criteria: Hemoglobin A1c Control (HbA1c) (<8 percent) (ACO-22) |
72.81% |
68.58% |
Beneficiaries with diabetes who met of all the following criteria: Low Density Lipoprotein (LDL) (< 100 mg/dL) (ACO-23) |
63.12% |
54.78% |
Beneficiaries with diabetes who met of all the following criteria: Blood Pressure (BP) < 140/90 (ACO-24) |
67.87% |
69.53% |
Beneficiaries with diabetes who met of all the following criteria: Tobacco Non-Use (ACO-25) |
58.37% |
63.33% |
Beneficiaries with diabetes who met of all the following criteria: Aspirin Use (ACO-26) |
87.13% |
74.82% |
Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) (ACO-27) |
14.26% |
22.11% |
Percent of beneficiaries with hypertension whose BP < 140/90 (ACO-28) |
68.34% |
67.79% |
Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl (ACO-29) |
68.77% |
55.44% |
Percent of beneficiaries who use Aspirin or other antithrombotic (ACO-30) |
87.38% |
76.35% |
Beta-Blocker Therapy for LVSD (ACO-31) |
93.75% |
79.82% |
Percent of beneficiaries with CAD who met all of the following criteria: Drug Therapy for Lowering LDL-Cholesterol (ACO-32) |
92.86% |
71.60% |
Percent of beneficiaries with CAD who met all of the following criteria: (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) (ACO-33) |
88.59% |
69.13% |
2014 Performance Summary Statistics |
||
Performance Measure |
ACO Performance Rate |
Mean Performance Rate for All ACOs |
Getting Timely Care, Appointments, and Information (ACO-1) |
63.46 |
80.13 |
How Well Your Doctors Communicate (ACO-2) |
89.22 |
92.39 |
Patients’ Rating of Doctor (ACO-3) |
90.16 |
91.58 |
Access to Specialists (ACO-4) |
76.73 |
83.97 |
Health Promotion and Education (ACO-5) |
64.82 |
58.29 |
Shared Decision Making (ACO-6) |
70.92 |
74.60 |
Health Status/Functional Status (ACO-7) |
71.13 |
71.10 |
Risk Standardized, All Condition Readmissions (ACO-8) |
15.64 |
15.15 |
ASC Admissions: COPD or Asthma in Older Adults (ACO-9) |
2.41 |
1.08 |
ASC Admission: Heart Failure (ACO-10) |
1.86 |
1.19 |
Percent of Primary Care Providers who Qualified for EHR Incentive Payment (ACO-11) |
16.42% |
76.71% |
Medication Reconciliation (ACO-12) |
95.73% |
82.61% |
Falls: Screening for Fall Risk (ACO-13) |
45.96% |
45.60% |
Influenza Immunization (ACO-14) |
76.87% |
57.51% |
Pneumococcal Vaccination (ACO-15) |
79.84% |
55.03% |
Adult Weight Screening and Follow-up (ACO-16) |
64.22% |
66.75% |
Tobacco Use Assessment and Cessation Intervention (ACO-17) |
87.32% |
86.79% |
Depression Screening (ACO-18) |
88.87% |
39.27% |
Colorectal Cancer Screening (ACO-19) |
70.96% |
56.14% |
Mammography Screening (ACO-20) |
76.14% |
61.41% |
Proportion of Adults who had blood pressure screened in past 2 years (ACO-21) |
78.46% |
60.24% |
Beneficiaries with diabetes who met of all the following criteria: Hemoglobin A1c Control (HbA1c) (<8 percent) (ACO-22) |
69.21% |
|
Beneficiaries with diabetes who met of all the following criteria: Low Density Lipoprotein (LDL) (< 100 mg/dL) (ACO-23) |
65.89% |
|
Beneficiaries with diabetes who met of all the following criteria: Blood Pressure (BP) < 140/90 (ACO-24) |
69.87% |
|
Beneficiaries with diabetes who met of all the following criteria: Tobacco Non-Use (ACO-25) |
80.79% |
|
Beneficiaries with diabetes who met of all the following criteria: Aspirin Use (ACO-26) |
90.28% |
|
Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) (ACO-27) |
16.39% |
20.35% |
Percent of beneficiaries with hypertension whose BP < 140/90 (ACO-28) |
63.71% |
68.02% |
Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl (ACO-29) |
70.68% |
57.29% |
Percent of beneficiaries who use Aspirin or other antithrombotic (ACO-30) |
93.46% |
80.79% |
Beta-Blocker Therapy for LVSD (ACO-31) |
89.62% |
82.71% |
Percent of beneficiaries with CAD who met all of the following criteria: Drug Therapy for Lowering LDL-Cholesterol (ACO-32) |
90.71% |
|
Percent of beneficiaries with CAD who met all of the following criteria: (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) (ACO-33) |
91.62% |
|
For more information on how to interpret scores on the above quality performance measures, see http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf.
For general questions or additional information regarding Accountable Care Organizations, please visit: www.medicare.gov/acos.html, or call 1-800-MEDICARE (1-800-633-4227 (TTY users should call 1-877-486-2048)).
